Bruker (BRKR) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
9 Jul, 2026Opening remarks and agenda
The meeting was opened virtually to increase inclusivity and reach more stockholders.
Key executives, directors, and representatives from the independent auditor were introduced.
Secretary Alldredge was appointed as Inspector of Elections.
Corporate governance
Notice of the meeting and proxy materials were distributed electronically or by mail to stockholders as of April 1, 2025.
A quorum was established with over 95% of shares represented virtually or by proxy.
Shareholder proposals
Four proposals were presented: election of four Class 1 Directors, advisory approval of 2024 executive compensation, ratification of PricewaterhouseCoopers as auditor for 2025, and approval of the 2026 Incentive Compensation Plan.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Bruker
- AI-driven multi-omics and diagnostics innovation, with strong growth in biopharma and deep tech.BRKR
Morgan Stanley 24th Annual Global Healthcare Conference - Strong order growth, deep tech expansion, and AI-driven automation fuel future leadership.BRKR
Wells Fargo 21st Annual Healthcare Conference - Q2 2026 saw revenue and margin growth, offset by a $134.9M goodwill impairment charge.BRKR
Q2 2026 - Order momentum, global growth, and cost savings set the stage for margin expansion through 2027.BRKR
Jefferies Global Healthcare Conference 2026 - Directors elected, executive pay approved, and auditors ratified for 2026.BRKR
AGM 2026 - Q1 2026 revenue up 2.7%, EPS down, but FY guidance reaffirmed with strong bookings and cost savings.BRKR
Q1 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.BRKR
Proxy filing - 2026 proxy covers director elections, say-on-pay, auditor ratification, and robust ESG and governance.BRKR
Proxy filing - FY25 revenue up 2.1% but margins fell; FY26 guidance targets EPS and margin expansion.BRKR
Q4 2025